ADDEX THERAPEUTICS LTD's ticker is ADXN and the CUSIP is 00654J107. A total of 5 filers reported holding ADDEX THERAPEUTICS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $40,000 | -31.0% | 50,000 | 0.0% | 0.02% | -36.8% |
Q2 2022 | $58,000 | -77.2% | 50,000 | 0.0% | 0.04% | -69.6% |
Q1 2022 | $254,000 | -19.4% | 50,000 | 0.0% | 0.12% | +9.6% |
Q4 2021 | $315,000 | -30.2% | 50,000 | 0.0% | 0.11% | -12.3% |
Q3 2021 | $451,000 | -5.6% | 50,000 | 0.0% | 0.13% | +5.7% |
Q2 2021 | $478,000 | – | 50,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 5,648,690 | $1,112,792 | 0.08% |
Endurant Capital Management LP | 120,748 | $114,252 | 0.06% |
Virtu Financial LLC | 42,912 | $41 | 0.00% |
OLD MISSION CAPITAL LLC | 65,720 | $62,184 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Citadel Advisors | 34,385 | $32,539 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,088 | $14,278 | 0.00% |
JANE STREET GROUP, LLC | 11,657 | $11,030 | 0.00% |